The National Institute of Neurology and Neurosurgery, is a public hospital in Mexico City. The hospital has 126 beds, for patients of neurosurgery, neurology, and psychiatry.

There are 126 beds in Instituto Nacional de Neurologia y Neurocirugia.

During the past decade, Instituto Nacional de Neurologia y Neurocirugia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Nacional de Neurologia y Neurocirugia" #1 sponsor was "El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez" with 6 trials, followed by "Washington University School of Medicine" with 4 trials sponsored, "GlaxoSmithKline" with 2 trials sponsored, "Distribuidora Biolife SA de CV" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Nacional de Neurologia y Neurocirugia" #1 collaborator was "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Alzheimer's Association" with 3 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 2 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Nacional de Neurologia y Neurocirugia" are "Alzheimers Disease" (3 trials), "Alzheimers Disease, Familial" (3 trials), "Dementia" (3 trials), "Alzheimer's Disease" (1 trials) and "Aneurysmal Subarachnoid Hemorrhage" (1 trials). Many other conditions were trialed in "Instituto Nacional de Neurologia y Neurocirugia" in a lesser frequency.

Most popular intervention types in "Instituto Nacional de Neurologia y Neurocirugia" are "Drug" (9 trials), "Other" (4 trials), "Device" (3 trials), "Dietary Supplement" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "E2814" (2 trials), "Gantenerumab" (2 trials), "Lecanemab" (2 trials) and "Matching Placebo (E2814)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Nacional de Neurologia y Neurocirugia" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Nacional de Neurologia y Neurocirugia". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Instituto Nacional de Neurologia y Neurocirugia, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Nacional de Neurologia y Neurocirugia, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".